Astria Therapeutics, Inc. (ATXS) NASDAQ

12.55

+0.04(+0.32%)

Updated at January 14 01:07PM

Currency In USD

Valuation

Market Cap502.08M
Enterprise Value447.61M
P/E Ratio-5.85
PEG Ratio0.99
Price/Sales Ratio1,011.52
Price/Book Ratio3.11
Enterprise/Revenue881.46
Enterprise/EBITDA-4.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-175.68
Operating Margin-193.36

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.45

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-111.56M
Net Income-94.26M
Diluted EPS-1.68

Balance Sheet

Total Cash227.72M
Total Cash/Share3.93
Total Debt4.46M
Total Debt/Equity0.02
Current Ratio10.78
Book Value Per Share4.02

Price History

52-Week Change69.74
52-Week High13.29
52-Week Low3.56
Moving Average 50 Days12.74
Moving Average 200 Days8.03

Statistics

Average Volume1.6M
Shares Outstanding57.08M
% Held by Institutions99.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:6
Last Split DateAugust 20, 2021